These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 12082849)
1. [Immunotherapy of cancer]. Andersen MH; Schmidt H; Gehl J; von der Maase H; Straten P Ugeskr Laeger; 2002 Jun; 164(23):3008-16. PubMed ID: 12082849 [TBL] [Abstract][Full Text] [Related]
2. Cancer immunotherapy. Schuster M; Nechansky A; Kircheis R Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244 [TBL] [Abstract][Full Text] [Related]
3. Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration. Andersen MH; Gehl J; Reker S; Pedersen LØ; Becker JC; Geertsen P; thor Straten P Semin Cancer Biol; 2003 Dec; 13(6):449-59. PubMed ID: 15001164 [TBL] [Abstract][Full Text] [Related]
4. Current developments in cancer vaccines and cellular immunotherapy. Ribas A; Butterfield LH; Glaspy JA; Economou JS J Clin Oncol; 2003 Jun; 21(12):2415-32. PubMed ID: 12805342 [TBL] [Abstract][Full Text] [Related]
5. Advances in specific immunotherapy for prostate cancer. Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335 [TBL] [Abstract][Full Text] [Related]
6. Tumor escape from the immune response: a major hurdle for successful immunotherapy of cancer? Chouaib S Tunis Med; 2005 Dec; 83 Suppl 12():7-10. PubMed ID: 16430055 [No Abstract] [Full Text] [Related]
7. Immunotherapeutic approaches for the treatment of malignant melanoma. Curiel-Lewandrowski C; Atkins MB Curr Opin Investig Drugs; 2001 Nov; 2(11):1553-63. PubMed ID: 11763157 [TBL] [Abstract][Full Text] [Related]
8. Regulators of apoptosis: suitable targets for immune therapy of cancer. Andersen MH; Becker JC; Straten Pt Nat Rev Drug Discov; 2005 May; 4(5):399-409. PubMed ID: 15864269 [TBL] [Abstract][Full Text] [Related]
13. Boosting the immune response: an alternative combination therapy for cancer patients. Thyphronitis G; Koutsilieris M Anticancer Res; 2004; 24(4):2443-53. PubMed ID: 15330197 [TBL] [Abstract][Full Text] [Related]
14. Immunobiology and gene-based immunotherapy of hepatocellular carcinoma. Geissler M; Mohr L; Ali MY; Grimm CF; Ritter M; Blum HE Z Gastroenterol; 2003 Nov; 41(11):1101-10. PubMed ID: 14648380 [TBL] [Abstract][Full Text] [Related]
15. Immune responses to human tumors: development of tumor vaccines. Platsoucas CD; Fincke JE; Pappas J; Jung WJ; Heckel M; Schwarting R; Magira E; Monos D; Freedman RS Anticancer Res; 2003; 23(3A):1969-96. PubMed ID: 12894571 [TBL] [Abstract][Full Text] [Related]
16. Cytokine-based therapy and biochemotherapy for advanced melanoma. Atkins MB Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2353s-2358s. PubMed ID: 16609058 [TBL] [Abstract][Full Text] [Related]
18. Tumor vaccine: current trends in antigen specific immunotherapy. Baral R Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903 [TBL] [Abstract][Full Text] [Related]